Form 4: Director Jeffrey Flier Increases Stake in Scholar Rock

Director Jeffrey S. Flier acquired 6,839 restricted stock units and 4,310 stock options in Scholar Rock Holding Corp.

Summary

• Director Jeffrey S. Flier received an equity grant consisting of 6,839 restricted stock units (RSUs) and 4,310 stock options.
• The RSUs are valued at $0.00 at the time of grant and represent a contingent right to receive common stock.
• The stock options have an exercise price of $45.33 per share.
• Following this transaction, the director's total beneficial ownership is 30,909 shares, including 24,070 common shares and 6,839 RSUs.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral for the stock price.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.
• Retention of experienced board leadership through standard equity vesting schedules.

Negatives

• Potential for future dilution of existing shareholders upon the exercise of options and vesting of RSUs.

Risks

• Market price volatility affecting the value of the granted options.
• Dependence on continued service to the issuer for the vesting of equity awards.

Future Outlook

The equity grants are subject to vesting conditions tied to the director's continued service through the earlier of the first anniversary of the grant or the next Annual Meeting.

Management Comments

• No specific management commentary provided in this regulatory filing.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are standard practice in the biotechnology sector to ensure board alignment with long-term clinical and commercial milestones.

Comparison to Industry Standards

• The grant structure follows standard corporate governance practices for mid-cap biotech firms.
• Vesting periods align with typical industry benchmarks for director compensation.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard director compensation event.

Next Steps

• Vesting of RSUs on June 15, 2027, or the date of the next Annual Meeting.
• Vesting of stock options on the first anniversary of the grant or the next Annual Meeting.

Key Dates

Keywords

Scholar Rock, SRRK, Insider Trading, Form 4, Equity Compensation, Biotech